NCT02145780

Brief Summary

Obesity is a complex and multifactorial disease representing a major public health challenge. Indeed, overweight and obese people carry a major risk of developing insulin resistance and type 2 diabetes mellitus. It has been demonstrated that polyphenols could be used to counteract some of the mechanisms involved in the generation of insulin resistance. The model of overfeeding represents a very good study model of the metabolic complications of obesity, since it has been shown to induce a transient state of insulin resistance in the human. The purpose of this research is to study the effects of a overfeeding (+50% of daily caloric needs over 31 days) with or without polyphenols supplementation (2g/days over 31 days) on insulin sensitivity measured in the setting of a hyperinsulinemic euglycemic clamp and on post prandial partitioning of exogenous lipids after a test meal. During 31 days, the volunteers will consume chocolate bars, chips, chocolate breads and cola in addition to their usual diet and will be supplemented with 2g of grape polyphenols extract or with placebo.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 13, 2014

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 23, 2014

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2017

Completed
Last Updated

August 23, 2017

Status Verified

August 1, 2017

Enrollment Period

3.2 years

First QC Date

May 13, 2014

Last Update Submit

August 22, 2017

Conditions

Keywords

OverfeedingFat distributionSubcutaneous and visceral adipose tissueInsulin sensitivityInsulin resistancePeripheral and hepatic insulin sensitivityStable isotopesLipid oxidationEnergy expenditureMuscle and subcutaneous adipose tissue gene expression

Outcome Measures

Primary Outcomes (1)

  • Peripheral insulin sensitivity

    Volunteers will have peripheral and hepatic insulin sensitivity determined by using a two-stage hyperinsulinemic euglycemic clamp with stable isotopically labeled tracer infusion.

    During 31 days

Secondary Outcomes (6)

  • Hepatic insulin sensitivity

    before and after the 31 days of overfeeding

  • Change in genes expression in adipose and muscle tissues

    Before and after the 31 days of overfeeding

  • Anthropometry, Fat quantification and Abdominal fat distribution

    During 31 days

  • Fasting and Postprandial partitioning of exogenous lipid

    Fasting and during all the postprandial period (0-300 minutes)

  • Modification in intestinal microbiota

    Before and after the 31 days of overfeeding

  • +1 more secondary outcomes

Study Arms (2)

2g of grape polyphenol extract supplement

EXPERIMENTAL

Men will have to consume daily 2g of grape polyphenol extract during the 31 days of overfeeding.

Dietary Supplement: 2g of grape polyphenol extract

2g of placebo (lactose)

PLACEBO COMPARATOR

Men will have to consume daily 2g of placebo during the 31 days of overfeeding.

Dietary Supplement: Dietary Supplement: 2g of placebo (lactose)

Interventions

Men will have to consume daily 2g of grape polyphenol extract during the 31 days of overfeeding.

2g of grape polyphenol extract supplement

Men will have to consume daily 2g of placebo during the 31 days of overfeeding.

2g of placebo (lactose)

Eligibility Criteria

Age18 Years - 55 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male
  • Aged from 18 to 55 years
  • Body Mass Index of 23 to 27 kg/m²
  • Normal blood pressure
  • Fasting glycemia \< 7 mmol/L
  • CRPus \< 10mg/L
  • Triglycerides ≤ 3mmol/L

You may not qualify if:

  • Medical or surgical history which may affect the results (renal -cardiovascular - hepatic- endocrine-inflammatory diseases)
  • Subjects under treatment which may interfere with the measured parameters
  • Eating disorder
  • Intensive sportive activity
  • Dairy products allergy or intolerance

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rhône Alpes Human Nutrition Center (CRNH Rhône-Alpes)

Pierre-Bénite, 69495, France

Location

Related Publications (2)

  • Bartova S, Madrid-Gambin F, Fernandez L, Carayol J, Meugnier E, Segrestin B, Delage P, Vionnet N, Boizot A, Laville M, Vidal H, Marco S, Hager J, Moco S. Grape polyphenols decrease circulating branched chain amino acids in overfed adults. Front Nutr. 2022 Oct 26;9:998044. doi: 10.3389/fnut.2022.998044. eCollection 2022.

  • Segrestin B, Delage P, Nemeth A, Seyssel K, Disse E, Nazare JA, Lambert-Porcheron S, Meiller L, Sauvinet V, Chanon S, Simon C, Ratiney H, Beuf O, Pralong F, Yassin NA, Boizot A, Gachet M, Burton-Pimentel KJ, Vidal H, Meugnier E, Vionnet N, Laville M. Polyphenol Supplementation Did Not Affect Insulin Sensitivity and Fat Deposition During One-Month Overfeeding in Randomized Placebo-Controlled Trials in Men and in Women. Front Nutr. 2022 May 9;9:854255. doi: 10.3389/fnut.2022.854255. eCollection 2022.

MeSH Terms

Conditions

Insulin Resistance

Interventions

Dietary SupplementsLactose

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesDisaccharidesOligosaccharidesPolysaccharidesCarbohydratesSugars

Study Officials

  • Martine LAVILLE, MD, PhD

    Rhône Alpes Human Nutrition Center (CRNH Rhône-Alpes)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 13, 2014

First Posted

May 23, 2014

Study Start

February 1, 2014

Primary Completion

May 1, 2017

Study Completion

May 1, 2017

Last Updated

August 23, 2017

Record last verified: 2017-08

Locations